Abstract

In the connection between inflammation and cancer development, tumor necrosis factor-alpha (TNF-α) contributes to the tumorigenesis. However, the underlying mechanism remains poorly understood. In this study, we report that TNF-α enhances the growth of breast cancer through up-regulation of oncoprotein hepatitis B X-interacting protein (HBXIP). Our data showed that the levels of TNF-α were positively related to those of HBXIP in clinical breast cancer tissues. Moreover, TNF-α could up-regulate HBXIP in breast cancer cells. Interestingly, silencing of TNF-α receptor 1 (TNFR1) blocked the effect of TNF-α on HBXIP. Mechanistically, we revealed that TNF-α could increase the activities of HBXIP promoter through activating transcriptional factor signal transducer and activator of transcription 3 (STAT3). In addition, nuclear factor kappa B (NF-κB) and/or p38 signaling increased the levels of p-STAT3 in the cells. Strikingly, HBXIP could also up-regulate TNFR1, forming a positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1. Notably, TNF-α was able to up-regulate TNFR1 through driving the loop. In function, we demonstrated that the knockdown of HBXIP remarkably abolished the growth of breast cancer mediated by TNF-α in vitro and in vivo. Thus, we conclude that TNF-α promotes the growth of breast cancer through the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1.Our finding provides new insights into the mechanism by which TNF-α drives oncoprotein HBXIP in the development of breast cancer.

Highlights

  • The links between inflammation and cancer become a hot topic for cancer

  • We report that TNF-α enhances the growth of breast cancer through up-regulation of oncoprotein hepatitis B X-interacting protein (HBXIP)

  • We demonstrated that the knockdown of HBXIP remarkably abolished the growth of breast cancer mediated by TNF-α in vitro and in vivo

Read more

Summary

Introduction

The links between inflammation and cancer become a hot topic for cancer. the underlying molecular mechanism remains unclear. The cancerrelated inflammation involving in the progression of cancer includes the presence of inflammatory cells and inflammatory mediators which including chemokines, cytokines and prostaglandins in cancer microenvironment [1, 2]. Tumor necrosis factor-alpha (TNF-α) is an important multifunctional inflammatory cytokine with pleiotropic actions, involving the regulation of apoptosis, survival and immune responses [3,4,5]. TNFR2 is restrictively expressed in immune cells and mediates limited biological functions, whereas TNFR1 is ubiquitously expressed in human tissues and serves as a major signaling receptor for TNF-α [9]. Inflammatory factor TNF-α is able to promote the growth, invasion, metastasis and lymphangiogenesis in cancer development [6, 7, 10,11,12,13]. The role of TNF-α in the development of breast cancer is not well documented

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call